TRANSNATIONALE.ORG
Subscribe ! Log in
Log out
SEARCH  web site
COMPANIES
Discover the reality of companies and brands !

Sanofi-Aventis

Headquarters : 174 avenue de France 75635 Paris Cedex 13 France France web www.sanofi-aventis.com tel. 33-1-53-77-44-45 email: investor-relations@sanofi-synthelabo.com analytics

Brands

name
click to compare prices
Allegra, Aprovel, Astra-Synthélabo
Bio-Organics
Cenovis, Chinoin Rt, Copaxone
Eloxatine
Irex
Laboratorios Kendrick, Lactacyd, Lantus, Lipofactor, Lovenox
Mitosyl
Nature's Own
Plavix
Sanofi-Aventis , Sanofi-Synthelabo , Stilnox
Taxotere, Tritace
» Shop local, ethical and at the best price on Ethishop
« ETHICAL » RATING OF SANOFI-AVENTIS , group and subsidiaries
[click on the rating for the method or on the number for the data]
Jobs -4% /1998 Pollution 5 Fraud 12 Offshore 3 Sales 28 Bn $.€ /year Profit 18 Bn $.€ /1998 Wage 2242 *min. Influence 10 Infocom 3
shareholdercountry%source
Berkshire Hathaway-Ci AUnited States of America0.3
EmployésWorld1
KPC CorpKuwait6.19
L'OréalFrance10.41
Sanofi-AventisFrance4.4AFP
State Street Corp.United States of America5Boursier.com
Total SAFrance12.99
» More shareholders of Sanofi-Aventis
year
business
source
2007Sanofi-Aventis SA, France's largest drugmaker
2007Sanofi-Aventis is France's largest drugmaker.
2006Sanofi-Aventis is the world's fourth-largest pharmaceutical group.Les Echos
2006Sanofi-Aventis sells 23% of the vaccines bought in the world.Les Echos
2004The world's third-largest pharmaceutical company with 70 plants in the world, 19 of which in France.
» More business descriptions and market shares for Sanofi-Aventis.
subsidiarycountry%source
Aventis SA France100
Genfit France Les Echos
Hoechst AG Germany100Cercle Finance
Sanofi France100
Sanofi-Aventis France4.4AFP
Zentiva Netherlands49.9Les Echos
» More subsidiaries of Sanofi-Aventis
country
address & contact : production type
incentive source
United States of America United States of America
Great Valley, Pennsylvanie : R&D
 Les Echos
France France
Montpellier : R&D
 Les Echos
France France
Toulouse : R&D
 Les Echos
France France
Chilly-Mazarin : R&D
 Les Echos
France France
Bagneux : R&D
 Les Echos
France France
Porcheville : R&D
 Les Echos
Hungary Hungary
Chinoin Rt :
 Les Echos
Mexico Mexico
Laboratorios Kendrick : Production, médicaments génériques
 Les Echos
United Kingdom United Kingdom
Alnwick : R&D
 Les Echos
» More locations of Sanofi-Aventis
» The World map of tax haven, secret accounts and shell companies

  • Human impact

year name
photo position; compensation
source
2008Viehbacher, Christopher
See the photo of: Viehbacher, Christopher Chief Executive Officer;
Les Echos
2004Laimay, Marie-Hélène
See the photo of: Laimay, Marie-Hélène Chief Financial Officer;
Boursorama
2002Dehecq, Jean-François
See the photo of: Dehecq, Jean-François Chief Executive Officer; salary: 1.9 million Eu€; stock-options: 6 million Eu€;
Les Echos
2001Dehecq, Jean-François
See the photo of: Dehecq, Jean-François Chief Executive Officer; salary: 4 million Eu€;
L'humanité
1999Barbier de la Serre, René
See the photo of: Barbier de la Serre, René Director;
1999Castaigne, Robert
See the photo of: Castaigne, Robert Director;
1999De Gennes, Pierre-Gilles
See the photo of: De Gennes, Pierre-Gilles Director;
1999Desmarest, Thierry
See the photo of: Desmarest, Thierry Director;
1999Martin, Pierre Castres Saint
See the photo of: Martin, Pierre Castres Saint Director;
1999Owen-Jones, Lindsay
See the photo of: Owen-Jones, Lindsay Director;
1999Weymuller, Bruno
See the photo of: Weymuller, Bruno Director;
1998Guérin, Hervé
See the photo of: Guérin, Hervé Chief Executive Officer;
Forbes
» More executive salaries for Sanofi-Aventis
» Highest paid executives in 2007
year
employees
<>
social impact : country
source
2008
-700
Internal restructuring: Sanofi-Aventis removes a third of its medical representatives jobs in France.: France
Reuters
2008
100000
-380
Internal restructuring: Sanofi-Aventis cuts 380 jobs of medical representatives in Germany.: Germany
L'Expansion
2007
-40
Internal restructuring: Canada
Les Echos
2007
-118
Internal restructuring: Sanofi-Aventis restructures its Neuville-on-Saone factory because of the fall of the sales of the Ketek drug.: France
Les Echos
2005
-504
Merger/Acquisition: Following the merger between Sanofi and Aventis, 500 workers have accepted an early retirement program. They will earn 70% of their former wage.: France
Les Echos
2004
-330
Internal restructuring:
La Vie Financière
2004
99700
2002
32436
2001
30514
2000
29200
» More restructuring at Sanofi-Aventis
» Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
 10 informations, access to subscribers
» More restructuring at Sanofi-Aventis
» Layoff plans and labour conditions in 2007
year
country : consequences
source
2006France : The International Chamber of Commerce of Paris confirmed the "environmental responsibility" of Sanofi for the underground pollution with mercury of the Vieux-Thann site.Les Echos
» More environmental impacts by Sanofi-Aventis
» Pollutions in 2007
year
country : consequences
source
 1 informations, access to subscribers
» More environmental impacts by Sanofi-Aventis
» Pollutions in 2007

  • Subsidy

yearfinancial misdemeanorsalesincome buybacksource
2008   1.227billion Eu€Les Echos
2007   1.787billion Eu€Les Echos
2007   28.056.96   billion Eu€
2007 Sanofi pays US$190 million to the US Department of Justice to settle allegations of fraud in the pricing and marketing of a drug used for cancer treatment side effects. From September 1997 to June 2004, Sanofi's subsidiary Aventis allegedly artificially inflate the price of the drug Anzemet, increasing the cost of government reimbursements for the drug.     AP
2006   27.756.57   billion Eu€
2004   1.53billion Eu€Boursier.com
2004   25   billion US$
2003   8.721.1   billion Eu€
2003   1billion Eu€AFP
2003   0.14billion Eu€Boursier.com
2002   7.451.58   billion Eu€
2001   6.490.98   billion Eu€
2000   5.960.62   billion Eu€
1999   5.35   billion Eu€
» More financial data for Sanofi-Aventis
» Financial delinquency in 2007
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 14 informations, access to subscribers
» More financial data for Sanofi-Aventis
» Financial delinquency in 2007
year
purpose : intermediary/lobby : institution
source
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
2000lift the ban on bovine growth hormon : FEDESA : : European Commission translateFedesa
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
» More influence from Sanofi-Aventis
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 3 informations, access to subscribers
» More influence from Sanofi-Aventis
» Influence in 2007
year
dubious practice : image
source
2005Arguable partnership: S'est allié à la fondation Drugs for Neglected Diseases Initiative pour la mise au point et la distribution d'ici 2006 d'un traitement à prix coûtant contre le paludisme. Le paludisme est une maladie délaissée par les centres de recherche des grands laboratoires privés. « On n'arrive pas à trouver une rentabilité, qui est à la base de nos projets de recherche, tout le monde le comprendra », explique Philippe Baetz, vice-président de Sanofi-Aventis.: value: Health; Libération
2004slogan: Nous refusons l'idée de ne pas développer les médicaments de demain pour un simple problème de taille;
1999slogan: L'essentiel, c'est la santé;
» More ads and public relations campaign from Sanofi-Aventis
» Dubious practices in 2007
Your contributions (0)
Information*
Name (or nickname)*
Email
Title*
Link to document online
Alert me of answers by email * required field
Please copy the antispam code:
All contributions
Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2009